<DOC>
	<DOC>NCT00563095</DOC>
	<brief_summary>Primary: To compare the efficacy of TACE and TAIE. Secondary: To compare the side effects of TACE and TAIE. The outcome measurements include survival benefit and tumour regression induced by the two therapies.</brief_summary>
	<brief_title>A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Confirmed hepatocellular carcinoma not suitable for surgery Portal vein thrombosis Severe arteriovenous shunt Bilirubin level &gt; 50 umol/mL Prothrombin time &gt; 5 seconds</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>